We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Pilot Study of Working Women and Breast Cancer

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01914614
First Posted: August 2, 2013
Last Update Posted: May 27, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Robin Vanderpool, University of Kentucky
  Purpose
The purpose of this research is to better understand the relationship between employment and breast cancer. Research is being conducted to understand how workplace factors influence breast cancer patients' ability to adhere to recommended cancer treatment and effectively recover from cancer. Investigators hope to use the findings from the study to help working breast cancer survivors make informed decisions about treatment and employment in collaboration with their employers and healthcare providers.

Condition
Breast Cancer

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: A Pilot Study of Working Women and Breast Cancer

Resource links provided by NLM:


Further study details as provided by Robin Vanderpool, University of Kentucky:

Primary Outcome Measures:
  • Guideline concordant breast cancer treatment as defined by National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology and oncologist assessments. [ Time Frame: 6 months ]
    Differences in receipt of guideline-concordant breast cancer treatment between working poor and working non-poor survivors as explained by variations in occupation and work organization factors associated with each group of women. Guideline-concordant treatment will be informed by National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology and oncologist assessments.


Secondary Outcome Measures:
  • Breast cancer treatment adherence, including completion of prescribed chemotherapy regimens, prescribed radiation treatment regimen, and/or surgical follow-up appointments. [ Time Frame: 6 months ]
    Differences in breast cancer treatment adherence rates between working poor and non-poor survivors as explained by variations in occupation and work organization factors associated with each group of women.

  • Satisfaction with breast cancer treatment decision-making [ Time Frame: 6 months ]
    Differences in satisfaction with breast cancer treatment decision-making between working poor and working non-poor survivors as explained by variations in occupation and work organization factors associated with each group of women.

  • Quality of life [ Time Frame: 6 months ]
    Differences in quality of life measures between working poor and working non-poor survivors explained by variations in occupation and work organization factors associated with each group of women.


Enrollment: 22
Study Start Date: November 2013
Study Completion Date: April 2015
Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
Working Poor Survivors
Low Wage workers
Non-Working Poor Survivors
Higher-Wage Salary Workers

Detailed Description:

Patients enrolled will be interviewed three times over a six month period. They will be asked questions about their experiences in managing their cancer while taking care of their job responsibilities. Patients will be asked to complete a survey that asks questions about their breast cancer treatment, their job, and how they manage their responsibilities while undergoing cancer treatment.

The first initial meeting will be conducted at a time and location that is convenient for the patient. This meeting should last about an hour to an hour and a half.

Three and six months after the initial interview, study participants will be asked to complete a follow-up survey by either telephone or Internet/Web, depending on their preference. These telephone surveys will last between 15-30 minutes.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Women diagnosed with a new, primary breast cancer within 3 months of enrollment and who were employed at the time of diagnosis.
Criteria

Inclusion Criteria:

  • Women age 18-65
  • Working at least 20 hours per week
  • Currently patients of the University of Kentucky Markey Cancer Center
  • Are able to read, write, and communicate in English
  • Have reliable telephone or Internet/Web access in or outside the home

Exclusion Criteria:

  • Self-employed
  • Unemployed
  • Cognitively impaired
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01914614


Locations
United States, Kentucky
UK Center for Clinical and Translational Science
Lexington, Kentucky, United States, 40536
University of Kentucky Markey Cancer Center
Lexington, Kentucky, United States, 40536
Sponsors and Collaborators
Robin Vanderpool
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Robin Vanderpool, DrPH University of Kentucky
  More Information

Responsible Party: Robin Vanderpool, Principal Investigator, University of Kentucky
ClinicalTrials.gov Identifier: NCT01914614     History of Changes
Other Study ID Numbers: IRB # 13-0560-P3H
K12DA035150 ( U.S. NIH Grant/Contract )
First Submitted: July 26, 2013
First Posted: August 2, 2013
Last Update Posted: May 27, 2015
Last Verified: May 2015

Keywords provided by Robin Vanderpool, University of Kentucky:
Breast Cancer
Working Women

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases